Filing Details

Accession Number:
0001104659-20-085615
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-22 16:03:53
Reporting Period:
2020-06-29
Accepted Time:
2020-07-22 16:03:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1760542 Hookipa Pharma Inc. HOOK () XX
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1441261 Fcpr Vi Capital Sofinnova C/O Hookipa Pharma Inc.
350 Fifth Avenue, 72Nd Floor, Suite 7240
New York NY 10118
No No Yes No
1574139 Sas Partners Sofinnova C/O Hookipa Pharma Inc.
350 Fifth Avenue, 72Nd Floor, Suite 7240
New York NY 10118
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-06-29 3,280 $11.78 3,960,574 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares sold pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.75 to $11.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any.